-
Epstein-Barr Virus May Help Spark Multiple Sclerosis, Study Finds
-
Cholera Bacterial Toxin Shows Promise Against Colorectal Cancer
-
How a Common Virus and a Gene Variant Team Up to Trigger MS
-
Georgetown Team Boosts Cancer-Fighting T Cells With PARP Drugs
-
Stem Cell Advance Brings Off-the-Shelf ‘Living Drugs’ Closer to Reality
-
Tiny Eye Cell ‘Twitch’ Could Transform Early Blindness Detection
-
Gene Therapy ‘Off Switch’ Aims to Ease Pain Without Addiction
-
How a Tumor-Suppressing Protein Could Boost Head and Neck Cancer Immunity
Researchers at MD Anderson have identified a tumor-suppressing protein that is shut down by excess glutamine in head and neck cancers, blunting the immune response. Blocking glutamine metabolism restored immune activity in preclinical models, pointing to a new way to help resistant tumors respond to treatment.
-
Breast Cancer Drug Shows Promise Against Deadly Leukemia
Oregon Health & Science University researchers have identified a drug duo that could help people with acute myeloid leukemia overcome treatment resistance. By pairing a standard leukemia drug with a breast cancer medicine, the team saw stronger, longer-lasting anti-cancer effects in lab and animal studies.
-
‘Molecular Glue’ Drug Strategy Targets Resistant Lung Cancer